PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling

Endogenous viruses: insights into viral evolution and impact on host biology

(2012) Cédric Feschotte et al.   NATURE REVIEWS GENETICS

PTEN Regulates PDGF Ligand Switch for β-PDGFR Signaling in Prostate Cancer

(2011) M. Katie Conley-LaComb et al.   AMERICAN JOURNAL OF PATHOLOGY

Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow

(2011) Yusuke Shiozawa et al.   JOURNAL OF CLINICAL INVESTIGATION

Loss of PTEN Permits CXCR4-Mediated Tumorigenesis through ERK1/2 in Prostate Cancer Cells

(2010) M. A. Chetram et al.   MOLECULAR CANCER RESEARCH

Effects of CXCR4 antagonist CTCE-9908 on prostate tumor growth

(2009) Stacy Porvasnik et al.   PROSTATE

PTEN and the PI3-Kinase Pathway in Cancer

(2008) Nader Chalhoub et al.   Annual Review of Pathology-Mechanisms of Disease

Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men

(2008) T. A. Wallace et al.   CANCER RESEARCH

Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer

(2008) Takuya Akashi et al.   CANCER SCIENCE

Tenets of PTEN Tumor Suppression

(2008) Leonardo Salmena et al.   CELL

CXCL12/CXCR4 Transactivates HER2 in Lipid Rafts of Prostate Cancer Cells and Promotes Growth of Metastatic Deposits in Bone

(2008) S. R. Chinni et al.   MOLECULAR CANCER RESEARCH